Anatomical-Clinical Base of Adenocarcinoma Pancreatic
Recruiting · NCT06128343 · Observational (researchers observe without assigning treatment) · Lead sponsor: University Hospital, Toulouse
View the official record on ClinicalTrials.gov →Interventions studied
collection of biological samples
What this trial is about
BACAP-2 is a prospective biobank dedicated to the pancreatic adenocarcinoma including clinical data and biological samples from tumor. The aim is to enrich the previous propective collection BACAP in order to support future research projects.
Who can take part
Age range
18 Years to 120 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patient with pancreatic mass syndrome explored by ultrasound endoscopy with cytopuncture or
- Patient with pancreatic mass syndrome explored by an abdominal scanner with and without injection of product contrast and/or puncture of the mass or secondary lesions by radiological route or
- Patient with pancreatic adenocarcinoma proven histologically and/or cytologically
Exclusion criteria
- Patient with a pancreatic tumor whose analysis histological is not an adenocarcinoma
- Pregnant or breastfeeding patient
Where it is running
8 locations listed.
- Haut-Lévêque Hospital - Bordeaux, France
- Béthune hospital center - Béthune, France
- Huriez Hospital - Lille, France
- Jean Mermoz private hosptila - Lyon, France
- Saint Eloi Hospital - Montpellier, France
- Regional Cancer Center From Montpellier - Montpellier, France
- PAU hospital - Pau, France
- Rangueil hospital - Toulouse, France